About us

The clinically proven X-halo technology for the first time empowers patients and caregivers with objective measurements of the state of inflammation in their lungs, allowing them to proactively make better informed lifestyles, medication and treatment choices. For healthcare professionals and researchers, the X-halo technology offers the prospect of personalised medicine for their patients available on a digital cloud-based platform.


Our Story

The development of an inexpensive, user-friendly device for EBT (Exhaled Breath Temperature) measurement was initiated by, Professor Todor Popov, in 2002.
After many years of dedicated research, Delmedica bought the rights to the technology and developed it further as the X-Halo. This was further refined in 2008, resulting in the Award Winning X-halo product.
We also hold the following regulatory clearances for the X-halo: